Latest Breaking News On - Case comprehensive cancer center - Page 1 : comparemela.com

Dr Carraway on the Importance of NGS in Relapsed/Refractory AML

Hetty E. Carraway, MD, MBA, discusses the importance of testing for targetable mutations in patients with relapsed/refractory acute myeloid leukemia.

Dr Deng on the Evolution of the Hodgkin Lymphoma Treatment Paradigm

Dr Deng on BTK Inhibitors vs Venetoclax-Based Treatment Regimens in CLL/SLL

AML, ALL, and Glioblastoma Multiforme Clinical Trials Seek to Push the Needle Forward

Leland Metheny, MD, discusses how agents such as Iomab-B have potential to shift practice in the hematologic malignancy space.

Dr Deng on the Benefits of Pirtobrutinib in CLL

Changchun Deng, MD, PhD, discusses the mechanism of action and advantageous features of pirtobrutinib for patients with chronic lymphocytic leukemia.